Cardiopulmonary phenotype associated with human PHD2 mutation

Physiological Reports

Volumn 5, Issue 7, 2017, Pages

  Talbot, Nick P ^a   Smith, Thomas G ^a   Balanos, George M ^b   Dorrington, Keith L ^a   Maxwell, Patrick H ^c   Robbins, Peter A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Hypoxia; hypoxia inducible factor; prolyl hydroxylase domain protein; pulmonary circulation; ventilation

Indexed keywords

HEMOGLOBIN; EGLN1 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE;

ADULT; ARTICLE; CARBON DIOXIDE TENSION; CARDIOPULMONARY FUNCTION; CASE REPORT; CONTROLLED STUDY; ERYTHROCYTOSIS; GENE; GENE ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; HEART OUTPUT; HUMAN; HYPOXIA; LUNG ARTERY PRESSURE; LUNG VENTILATION; MALE; OXYGEN SENSING; PHD2 GENE; PHENOTYPE; POLYCYTHEMIA; UPREGULATION; BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; GENETICS; HEART RATE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIROMETRY;

ADULT; BLOOD PRESSURE; CARDIAC OUTPUT; ECHOCARDIOGRAPHY, DOPPLER; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; MALE; MUTATION; PHENOTYPE; POLYCYTHEMIA; SPIROMETRY;

EID: 85017532095     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.13224     Document Type: Article

References (33)

1. Ang, S. O., H. Chen, K. Hirota, V. R. Gordeuk, J. Jelinek, Y. Guan, et al. 2002. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32:614–621.
2. Appelhoff, R. J., Y. M. Tian, R. R. Raval, H. Turley, A. L. Harris, C. W. Pugh, et al. 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279:38458–38465.
3. Bento, C., M. J. Percy, B. Gardie, T. M. Maia, R. van Wijk, S. Perrotta, et al. 2014. Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum. Mutat. 35:15–26.
4. Bishop, T., N. P. Talbot, P. J. Turner, L. G. Nicholls, A. Pascual, E. J. Hodson, et al. 2013. Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2. J. Physiol. 591:3565–3577.
5. Bond, J., D. P. Gale, T. Connor, S. Adams, J. de Boer, D. M. Gascoyne, et al. 2011. Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension. Blood 117:3699–3701.
6. Brigandi, R. A., B. Johnson, C. Oei, M. Westerman, G. Olbina, Zoysa. J. De, et al. 2016. A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for Anemia in CKD: a 28-day, phase 2A randomized trial. Am. J. Kidney Dis. 67:861–871.
7. Bushuev, V. I., G. Y. Miasnikova, A. I. Sergueeva, L. A. Polyakova, D. Okhotin, P. R. Gaskin, et al. 2006. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 91:744–749.
8. Camps, C., N. Petousi, C. Bento, H. Cario, R. R. Copley, M. F. McMullin, et al. 2016. Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations. Haematologica 101:1306–1318.
9. Dai, Z., M. Li, J. Wharton, M. M. Zhu, and Y. Y. Zhao. 2016. Prolyl-4 Hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through Hypoxia-Inducible Factor-2alpha. Circulation 133:2447–2458.
10. Epstein, A. C., J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, et al. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43–54.
11. Formenti, F., P. A. Beer, Q. P. Croft, K. L. Dorrington, D. P. Gale, T. R. Lappin, et al. 2011. Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation. FASEB J. 25:2001–2011.
12. Frise, M. C., H. Y. Cheng, A. H. Nickol, M. K. Curtis, K. A. Pollard, D. J. Roberts, et al. 2016. Clinical iron deficiency disturbs normal human responses to hypoxia. J. Clin. Invest. 126:2139–2150.
13. Gale, D. P., S. K. Harten, C. D. Reid, E. G. Tuddenham, and P. H. Maxwell. 2008. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 alpha mutation. Blood 112:919–921.
14. Hickey, M. M., T. Richardson, T. Wang, M. Mosqueira, E. Arguiri, H. Yu, et al. 2010. The von hippel-lindau chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J. Clin. Invest. 120:827–839.
15. Hodson, E. J., L. G. Nicholls, P. J. Turner, R. Llyr, J. W. Fielding, G. Douglas, et al. 2016. Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway. J. Physiol. 594:1179–1195.
16. 2 sensing. Science 292:464–468.
17. 2-regulated prolyl hydroxylation. Science 292:468–472.
18. Kapitsinou, P. P., G. Rajendran, L. Astleford, M. Michael, M. P. Schonfeld, T. Fields, et al. 2016. The endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 axis regulates pulmonary artery pressure in mice. Mol. Cell. Biol. 36:1584–1594.
19. McMullin, M. F. 2016. Congenital erythrocytosis. Int. J. Lab. Hematol. 38(Suppl 1):59–65.
20. Percy, M. J., Q. Zhao, A. Flores, C. Harrison, T. R. Lappin, P. H. Maxwell, et al. 2006. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl Acad. Sci. USA 103:654–659.
21. Provenzano, R., A. Besarab, S. Wright, S. Dua, S. Zeig, P. Nguyen, et al. 2016. Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6- to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. Am. J. Kidney Dis. 67:912–924.
22. Robbins, P. A., G. D. Swanson, and M. G. Howson. 1982. A prediction-correction scheme for forcing alveolar gases along certain time courses. J. Appl. Physiol. 52:1353–1357.
23. Russell, R. C., R. I. Sufan, B. Zhou, P. Heir, S. Bunda, S. S. Sybingco, et al. 2011. Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nat. Med. 17:845–853.
24. Sable, C. A., Z. Y. Aliyu, N. Dham, M. Nouraie, V. Sachdev, S. Sidenko, et al. 2012. Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia). Haematologica 97:193–200.
25. Sarangi, S., L. Lanikova, K. Kapralova, S. Acharya, S. Swierczek, J. M. Lipton, et al. 2014. The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension. Pediatr. Blood Cancer 61:2104–2106.
26. Schodel, J., S. Oikonomopoulos, J. Ragoussis, C. W. Pugh, P. J. Ratcliffe, and D. R. Mole. 2011. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117:e207–e217.
27. Smith, T. G., J. T. Brooks, G. M. Balanos, T. R. Lappin, D. M. Layton, D. L. Leedham, et al. 2006. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med. 3:e290.
28. Smith, T. G., G. M. Balanos, Q. P. Croft, N. P. Talbot, K. L. Dorrington, P. J. Ratcliffe, et al. 2008a. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J. Physiol. 586:5999–6005.
29. Smith, T. G., J. T. Brooks, G. M. Balanos, T. R. Lappin, D. M. Layton, D. L. Leedham, et al. 2008b. Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology. Adv. Exp. Med. Biol. 605:51–56.
30. Smith, T. G., R. W. Chang, P. A. Robbins, and K. L. Dorrington. 2013. Commercial air travel and in-flight pulmonary hypertension. Aviat. Space Environ. Med. 84:65–67.
31. Turner, B. E., P. D. Hodkinson, A. C. Timperley, and T. G. Smith. 2015. Pulmonary artery pressure response to simulated air travel in a hypobaric chamber. Aerosp. Med. Hum. Perform. 86:529–534.
32. Wang, G. L., and G. L. Semenza. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610–3615.
33. 2 tension. Proc. Natl Acad. Sci. USA 92:5510–5514.